Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Bleeding

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Bleeding in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Detter, MR1
Shenkar, R1
Benavides, CR1
Neilson, CA1
Moore, T1
Lightle, R1
Hobson, N1
Shen, L1
Cao, Y1
Girard, R1
Zhang, D1
Griffin, E1
Gallione, CJ1
Awad, IA1
Marchuk, DA1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Bleeding

ArticleYear
Novel Murine Models of Cerebral Cavernous Malformations.
    Angiogenesis, 2020, Volume: 23, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Disease; Animals; Apoptosis Regulatory Proteins

2020